• BioBoom

Sorrento Therapeutics: Two Month News Recap

Updated: Aug 1, 2020

It has been quite an eventful month of news for Sorrento Therapeutics, and since this site just went live, I thought it would be nice to do a two month news recap instead of 1 month recap. First link above photo directs you to the Sorrento Therapeutics website, and below the photo you have links to articles that did a good writeup on the news release. Next post will have a tentative timeline for all these events to actually get the GO from the FDA. Don't forget to sign up for the newsletter and become a member of this growing community of biotech investors/traders.

July 29, 2020

Sorrento Announces License From Columbia University For Rapid On-Site Detection Test For SARS-CoV-2 Virus In Saliva

Jul 24, 2020

Sorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies To Treat COVID-19 and Cancer Therapeutics

Jul 20, 2020

FDA clears Abivertinib for Phase 2 safety and efficacy study in hospitalized patients with moderate to severe COVID-19

July 01, 2020

Sorrento Announces Selection of T-VIVA-19™ as Targeted Protein Vaccine Candidate for SARS-CoV-2

Jun 12, 2020

Sorrento Announces Full Repayment of Outstanding Term Loans

8k Of full Repayment Of Loans

Jun 10, 2020

Sorrento Announces It Has Submitted an Emergency Use Authorization (EUA) Application for the COVI-TRACK Diagnostic Test for the Detection of Antibodies to SARS-CoV-2

Jun 05, 2020

Sorrento COVIDTRAP™(STI-4398) Demonstrates in Preclinical Studies its Ability to Completely Inhibit SARS-CoV-2 Viral Infection In Vitro

700 views0 comments

Recent Posts

See All